Erratum to prognostic value of skeletal muscle index and monocyte-to-lymphocyte ratio for lymph node-positive breast cancer patients after mastectomy

Prognostic value of skeletal muscle index and monocyte-to-lymphocyte ratio for lymph node-positive breast cancer patients after mastectomy

In the article entitled “Prognostic value of skeletal muscle index and monocyte-to-lymphocyte ratio for lymph node-positive breast cancer patients after mastectomy” (1), there are some errors.

In Figure S1, the P value were not correct, the corrected version is as follows (Figure S1).

Figure S1 Kaplan-Meier curves showing the RFS and DFS rates of groups based on SMI (A,B) and MLR (C,D). RFS, recurrence-free survival; DFS, disease-free survival; SMI, skeletal muscle index; MLR, monocyte-to-lymphocyte ratio.

Also, in line 167 to 171, the sentences “In addition, the patient with high SMI had significantly worse DFS (P=0.044; Figure S1A) and RFS (P=0.021; Figure S1B), and those with high MLR had worse DFS (P=0.002; Figure S1C) while their RFS (P>0.05; Figure S1D) were not significantly different from low-MLR-group’s.” should be replaced by the following content: “Besides, the patient with high MLR had significantly worse DFS (P=0.005; Figure S1C) and RFS (P=0.032; Figure S1D) compared with the low-MLR-group, while patients with high SMI have similar DFS and RFS (all P>0.05; Figure S1A,B) with the low-SMI-group’s.”

We regret the errors.

References

1. Deng JP, Hua X, Long ZQ, et al. Prognostic value of skeletal muscle index and monocyte-to-lymphocyte ratio for lymph node-positive breast cancer patients after mastectomy. Ann Transl Med 2019;7:775. [Crossref] [PubMed]